Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association
- PMID: 18087761
- DOI: 10.1007/s10067-007-0810-z
Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association
Abstract
Anticyclic citrullinated peptide antibodies (anti-CCP) have been described almost exclusively in patients with rheumatoid arthritis. Recently, these autoantibodies have been found in patients with active tuberculosis. Leprosy is another mycobacterial disease where the presence of autoantibodies has been described by several authors. In this study, 64 patients with leprosy (32 paucibacillary and 32 multibacillary forms of the disease) were evaluated and only 2 patients were positive for the presence of anti-CCP. The low frequency of anti-CCP in leprosy sera demonstrated in our study illustrates the high specificity of anti-CCP for the diagnosis of rheumatoid arthritis.
Comment in
-
Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association.Clin Rheumatol. 2010 Mar;29(3):335-6. doi: 10.1007/s10067-009-1327-4. Epub 2010 Jan 6. Clin Rheumatol. 2010. PMID: 20052511 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
